이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Shanghai Aladdin Biochemical TechnologyLtd 미래 성장

Future 기준 확인 5/6

Shanghai Aladdin Biochemical TechnologyLtd (는) 각각 연간 48.6% 및 23.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 55.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 13.5% 로 예상됩니다.

주요 정보

48.6%

수익 성장률

55.9%

EPS 성장률

Chemicals 수익 성장	30.5%
매출 성장률	23.6%
향후 자기자본 수익률	13.5%
애널리스트 커버리지	Low
마지막 업데이트	20 May 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

Cautious Investors Not Rewarding Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) Performance Completely

Jun 06

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Apr 23

수익 및 매출 성장 예측

SHSE:688179 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	800	N/A	N/A	136	1
12/31/2025	661	228	N/A	54	1
12/31/2024	512	177	N/A	150	1
3/31/2024	415	86	46	92	N/A
12/31/2023	403	86	10	56	N/A
9/30/2023	395	82	-42	5	N/A
6/30/2023	386	73	-122	-50	N/A
3/31/2023	373	79	-118	-51	N/A
12/31/2022	378	93	-105	-43	N/A
9/30/2022	356	95	-162	-45	N/A
6/30/2022	335	98	-90	-12	N/A
3/31/2022	317	100	-99	3	N/A
12/31/2021	288	89	-98	15	N/A
9/30/2021	272	86	-4	49	N/A
6/30/2021	273	92	22	75	N/A
3/31/2021	261	86	62	88	N/A
12/31/2020	234	74	72	81	N/A
9/30/2020	223	68	62	70	N/A
6/30/2020	206	59	56	63	N/A
3/31/2020	203	60	47	54	N/A
12/31/2019	210	64	50	56	N/A
9/30/2019	200	64	52	63	N/A
6/30/2019	188	60	34	46	N/A
3/31/2019	176	61	21	35	N/A
1/1/2019	166	53	28	39	N/A
9/30/2018	158	46	2	5	N/A
6/30/2018	148	44	19	24	N/A
3/31/2018	137	34	20	29	N/A
1/1/2018	126	32	N/A	33	N/A
9/30/2017	112	26	N/A	41	N/A
6/30/2017	111	24	N/A	39	N/A
3/31/2017	105	23	N/A	31	N/A
1/1/2017	106	21	N/A	31	N/A
9/30/2016	105	25	N/A	27	N/A
6/30/2016	104	28	N/A	22	N/A
3/31/2016	102	29	N/A	16	N/A
1/1/2016	101	30	N/A	10	N/A
9/30/2015	94	27	N/A	12	N/A
6/30/2015	87	25	N/A	14	N/A
3/31/2015	84	25	N/A	23	N/A
12/31/2014	80	25	N/A	31	N/A
9/30/2014	77	23	N/A	28	N/A
6/30/2014	73	21	N/A	24	N/A
3/31/2014	69	20	N/A	17	N/A
1/1/2014	65	19	N/A	10	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 688179 의 연간 예상 수익 증가율( 48.6% )이 saving rate( 2.9% 보다 높습니다. ).

수익 vs 시장: 688179 의 연간 수익( 48.6% ) CN 시장( 22.6% 보다 빠르게 성장할 것으로 예상됩니다. 22.6% 연간).

고성장 수익: 688179 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: 688179 의 수익(연간 23.6% ) CN 시장( 13.9% 보다 빠르게 성장할 것으로 예상됩니다. 13.9% 연간).

고성장 수익: 688179 의 수익(연간 23.6% )은 연간 20% 보다 빠르게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 688179 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 13.5 %).

Shanghai Aladdin Biochemical TechnologyLtd 미래 성장

Future 기준 확인 5/6

주요 정보

최근 미래 성장 업데이트

Recent updates

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 31, 2024

Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179) announces an Equity Buyback for CNY 15 million worth of its shares.

Cautious Investors Not Rewarding Shanghai Aladdin Biochemical Technology Co.,Ltd.'s (SHSE:688179) Performance Completely

First quarter 2024 earnings released: EPS: CN¥0.09 (vs CN¥0.086 in 1Q 2023)

Is Now An Opportune Moment To Examine Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179)?

Shanghai Aladdin Biochemical Technology Co.,Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 16%

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.074 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.074 (vs CN¥0.099 in 2Q 2022)

Investor sentiment deteriorates as stock falls 29%

Shanghai Aladdin Biochemical Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.22 in 1Q 2022)

Full year 2022 earnings released: EPS: CN¥0.67 (vs CN¥0.64 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.13 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.15 in 2Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.31 (vs CN¥0.20 in 1Q 2021)

Full year 2021 earnings released: EPS: CN¥0.89 (vs CN¥0.93 in FY 2020)

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.18 (vs CN¥0.32 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.21 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.93 (vs CN¥0.84 in FY 2019)

New 90-day high: CN¥106

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견